HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J N Moreira Selected Research

arginyl- tryptophyl- N- methylphenylalanyl- tryptophyl- leucyl- methioninamide

8/2004Antagonist G-mediated targeting and cytotoxicity of liposomal doxorubicin in NCI-H82 variant small cell lung cancer.
10/2001A growth factor antagonist as a targeting agent for sterically stabilized liposomes in human small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J N Moreira Research Topics

Disease

4Neoplasms (Cancer)
12/2008 - 12/2001
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2008 - 10/2001
2Seizures (Absence Seizure)
09/2021 - 10/2019
1Epilepsy (Aura)
10/2019

Drug/Important Bio-Agent (IBA)

3Liposomes (Liposome)IBA
08/2004 - 10/2001
2LipidsIBA
10/2019 - 05/2008
2arginyl- tryptophyl- N- methylphenylalanyl- tryptophyl- leucyl- methioninamideIBA
08/2004 - 10/2001
2Doxorubicin (Adriamycin)FDA LinkGeneric
08/2004 - 12/2001
1Diazepam (Valium)FDA LinkGeneric
09/2021
1Pharmaceutical PreparationsIBA
09/2021
1Proteins (Proteins, Gene)FDA Link
12/2008
1Biological ProductsIBA
05/2008
1liposomal doxorubicin (Doxil)FDA Link
08/2004
1LigandsIBA
12/2001
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
10/2001
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2001

Therapy/Procedure

1Drug Therapy (Chemotherapy)
08/2004
1Therapeutics
12/2001
1Injections
12/2001